ObsEva SA, en liquidation is a Switzerland-based company which provides services in the fields of research, development, manufacture, registration, promotion and marketing of biotechnical and pharmaceutical products.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	4.1M 3.55M 3.31M 3.05M 5.75M 390M 5.81M 38.91M 15.27M 195M 15.4M 15.06M 646M	P/E 2021	-2.57x	P/E 2022	-0.45x
Enterprise Value	-1.3M -1.12M -1.05M -962K -1.82M -123M -1.84M -12.29M -4.83M -61.65M -4.87M -4.76M -204M	EV / Sales 2021	-	EV / Sales 2022	0.65x
Free-Float	70.16%	Yield 2021 *	-	Yield 2022	-

21/04/23	ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq	MT
20/04/23	ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9%	MT
12/04/23	Insider Buy: Obseva	MT
06/04/23	ObsEva SA announced that it has received CHF 0.344 million in funding	CI
01/04/23	ObsEva SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
31/03/23	ObsEva SA Auditor Raises 'Going Concern' Doubt	CI
22/03/23	ObsEva SA(OTCPK:OBSV.F) dropped from NASDAQ Composite Index	CI
15/03/23	ObsEva to Delist from Nasdaq, Deregister from US SEC	MT
14/03/23	ObsEva Names New CEO From May, Appoints Interim Chairman	MT
13/03/23	ObsEva Names New Interim Chairman, CEO as Reorganization Continues	MT
13/03/23	ObsEva SA Announces CEO Changes, Effective on or About May 1, 2023	CI
13/03/23	ObsEva SA Announces Executive Changes	CI
03/03/23	Top Premarket Gainers	MT

30/08/22	HC Wainwright Downgrades ObsEva to Neutral from Buy	MT
01/08/22	Canaccord Genuity Downgrades ObsEva to Hold From Buy, Adjusts Price Target to $1 From $12	MT
29/07/22	Cantor Fitzgerald Cuts ObsEva to Neutral From Overweight, Price Target to $1 From $6	MT
03/06/22	Cantor Fitzgerald Starts ObsEva at Overweight With $6 Price Target	MT
26/04/22	Canaccord Genuity Starts ObsEva at Buy With $12 Price Target	MT

20/04/23	ObsEva Announces Change of Central Securities Depositary	GL
20/04/23	ObsEva Announces Change of Central Securities Depositary	GL
01/04/23	ObsEva Files Year End 2022 Financial Statements	GL
23/03/23	OBSEVA SA : Other Events (form 8-K)	AQ
15/03/23	ObsEva : Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange - Form 8-K	PU

20/04/23	Obseva-Aktien erhalten im Zuge von Nasdaq-Dekotierung neue ISIN-Nummer
06/04/23	Bourse Zurich: le SMI maintient ses gains à l'approche de la mi-journée
06/04/23	Bourse Zurich: ouverture en hausse avant le long week-end pascal
01/04/23	Obseva bleibt 2022 tief in den roten Zahlen
01/04/23	Obseva reste profondément en rouge en 2022, doutes sur la suite

ObsEva SA Stock Swiss Exchange

Stocks

OBSN

CH1260041939

Biotechnology & Medical Research

Valuation: ObsEva SA

Latest news : ObsEva SA

Analysts' recommendations: ObsEva SA

Press Releases: ObsEva SA

News in other languages: ObsEva SA

Quotes and Performance

Bio Therapeutic Drugs

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OBSEVA SA	-76.92%	-86.36%	-	-	117
WUXI APPTEC CO., LTD.	+4.35%	+19.90%	+60.59%	+95.21%	62.53B
ARGENX SE	+2.83%	-3.48%	+24.97%	+69.33%	52.43B
BIONTECH SE	-0.38%	-2.10%	-18.07%	-7.61%	23.1B
INSMED INCORPORATED	+1.81%	-2.70%	-10.10%	+358.80%	21.4B
WUXI BIOLOGICS (CAYMAN) INC.	+0.40%	+5.29%	+30.11%	-9.63%	21.17B
GENMAB A/S	+0.75%	+1.34%	+32.22%	-25.54%	17.76B
PHARMAESSENTIA CORPORATION	+9.88%	+19.73%	+229.67%	+385.49%	15.47B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+2.08%	-3.28%	+21.67%	+564.59%	14.68B
EXELIXIS, INC.	+0.80%	+1.97%	+50.61%	+178.62%	14.08B
Average	-5.46%	+3.65%	+46.85%	+178.81%	26.96B
Weighted average by Cap.	+2.73%	+4.59%	+42.27%	+136.84%

	2021	2022
Net sales	-	19.64M 17.01M 15.85M 14.58M 27.53M 1.87B 27.84M 186M 73.12M 934M 73.75M 72.13M 3.09B
Net income	-58.38M -50.56M -47.13M -43.35M -81.84M -5.55B -82.75M -554M -217M -2.78B -219M -214M -9.2B	-29.88M -25.88M -24.12M -22.19M -41.89M -2.84B -42.35M -283M -111M -1.42B -112M -110M -4.71B
Net Debt	-28.08M -24.32M -22.67M -20.85M -39.36M -2.67B -39.8M -266M -105M -1.34B -105M -103M -4.42B	-5.4M -4.67M -4.36M -4.01M -7.57M -513M -7.65M -51.2M -20.1M -257M -20.27M -19.82M -850M